Altria Group, Inc.
Regulated industryPhysical productsConsumer brandTags from an AI model reading the company description.
Fundamentals are temporarily unavailable for MO.
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $20.69B | $20.50B | $20.44B | $20.14B |
| Cost of Revenue | $6.44B | $6.22B | $6.08B | $5.60B |
| Gross Profit | $14.25B | $14.28B | $14.37B | $14.54B |
| Selling, General & Admin | $2.33B | $2.74B | $2.74B | $2.51B |
| Operating Expenses | $2.33B | $2.74B | $2.74B | $2.51B |
| Operating Income | $11.92B | $11.55B | $11.63B | $12.04B |
| EBITDA | $8.74B | $12.35B | $15.07B | $10.83B |
| Pretax Income | $7.39B | $10.93B | $13.66B | $9.39B |
| Income Tax | $1.63B | $2.80B | $2.39B | $2.44B |
| Net Income | $5.76B | $8.13B | $11.26B | $6.95B |
| Diluted EPS | 3.19 | 4.57 | 6.54 | 4.12 |
| Diluted Shares | 1.80B | 1.78B | 1.72B | 1.68B |
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & Equivalents | $4.03B | $3.69B | $3.13B | $4.47B |
| Receivables | $1.87B | $567.00M | $177.00M | $263.00M |
| Inventory | $1.18B | $1.22B | $1.08B | $1.07B |
| Current Assets | $7.22B | $5.58B | $4.51B | $5.93B |
| Total Assets | $36.95B | $38.57B | $35.18B | $35.02B |
| Current Liabilities | $8.62B | $11.32B | $8.78B | $9.15B |
| Long-Term Debt | $25.12B | $25.11B | $23.40B | $24.14B |
| Total Debt | $26.68B | $26.23B | $24.93B | $25.71B |
| Total Liabilities | $40.88B | $42.06B | $37.37B | $38.47B |
| Retained Earnings | $29.79B | $31.09B | $35.52B | $35.45B |
| Shareholders' Equity | -$3.97B | -$3.54B | -$2.24B | -$3.50B |
| Working Capital | -$1.40B | -$5.73B | -$4.27B | -$3.22B |
| Net Debt | $22.65B | $22.55B | $21.80B | $21.23B |
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating Cash Flow | $8.26B | $9.29B | $8.75B | $9.29B |
| Capital Expenditure | -$205.00M | -$196.00M | -$142.00M | -$216.00M |
| Free Cash Flow | $8.05B | $9.09B | $8.61B | $9.07B |
| Depreciation & Amortisation | $226.00M | $272.00M | $286.00M | $266.00M |
| Investing Cash Flow | $782.00M | -$1.28B | $2.17B | -$341.00M |
| Financing Cash Flow | -$9.54B | -$8.37B | -$11.49B | -$7.62B |
| Dividends Paid | -$6.60B | -$6.78B | -$6.84B | -$6.96B |
| Share Repurchases | -$1.82B | -$1.00B | -$3.40B | -$1.00B |
| Net Change in Cash | -$503.00M | -$370.00M | -$563.00M | $1.33B |
| USD | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | $5.29B | $5.25B | $5.08B | $4.76B | $5.36B |
| Cost of Revenue | $1.44B | $1.44B | $1.45B | $1.25B | $1.54B |
| Gross Profit | $3.85B | $3.81B | $3.63B | $3.51B | $3.82B |
| Selling, General & Admin | $619.00M | $580.00M | $720.00M | $550.00M | $663.00M |
| Operating Expenses | $619.00M | $580.00M | $720.00M | $550.00M | $663.00M |
| Operating Income | $3.23B | $3.23B | $2.91B | $2.96B | $3.16B |
| EBITDA | $3.46B | $3.42B | $1.93B | $3.17B | $3.28B |
| Pretax Income | $3.12B | $3.08B | $1.51B | $2.86B | $2.93B |
| Income Tax | $740.00M | $700.00M | $396.00M | $676.00M | $631.00M |
| Net Income | $2.38B | $2.38B | $1.12B | $2.18B | $2.30B |
| Diluted EPS | 1.41 | 1.41 | — | 1.30 | 1.37 |
| Diluted Shares | 1.68B | 1.68B | — | 1.67B | 1.67B |
| USD | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.29B | $3.47B | $4.47B | $3.53B | $2.37B |
| Receivables | $241.00M | $249.00M | $263.00M | $284.00M | $306.00M |
| Inventory | $1.02B | $1.06B | $1.07B | $1.15B | $1.06B |
| Current Assets | $2.63B | $5.12B | $5.93B | $5.20B | $4.02B |
| Total Assets | $32.33B | $35.01B | $35.02B | $34.58B | $33.37B |
| Current Liabilities | $6.79B | $8.29B | $9.15B | $8.41B | $7.77B |
| Long-Term Debt | $23.65B | $24.13B | $24.14B | $24.06B | $22.89B |
| Total Debt | $24.72B | $25.70B | $25.71B | $24.60B | $24.58B |
| Total Liabilities | $35.54B | $37.60B | $38.47B | $37.74B | $35.99B |
| Retained Earnings | $35.52B | $36.12B | $35.45B | $35.86B | $36.38B |
| Shareholders' Equity | -$3.26B | -$2.65B | -$3.50B | -$3.21B | -$2.67B |
| Working Capital | -$4.16B | -$3.17B | -$3.22B | -$3.21B | -$3.75B |
| Net Debt | $23.43B | $22.23B | $21.23B | $21.07B | $22.21B |
| USD | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $205.00M | $3.09B | $3.27B | $2.32B | $719.00M |
| Capital Expenditure | -$32.00M | -$54.00M | -$92.00M | -$93.00M | -$57.00M |
| Free Cash Flow | $173.00M | $3.04B | $3.18B | $2.23B | $662.00M |
| Depreciation & Amortisation | $71.00M | $70.00M | $54.00M | $56.00M | $56.00M |
| Investing Cash Flow | -$36.00M | -$60.00M | -$202.00M | -$109.00M | -$57.00M |
| Financing Cash Flow | -$3.61B | -$849.00M | -$2.07B | -$3.16B | -$1.83B |
| Dividends Paid | -$1.72B | -$1.72B | -$1.78B | -$1.78B | -$1.78B |
| Share Repurchases | -$274.00M | -$112.00M | -$288.00M | -$280.00M | -$55.00M |
| Net Change in Cash | -$3.44B | $2.19B | $996.00M | -$942.00M | -$1.17B |
Market Snapshot
About
Altria Group manufactures and markets tobacco products in the United States, primarily Marlboro cigarettes. The company also produces smokeless tobacco products and has investments in cannabis and vaping companies.